Yu, H., Mei, X., Zhang, X., Qian, N., Yu, Q., & Zhou, H. (2024). SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling. Bangladesh Journal of Pharmacology, 19(2), 52–58. https://doi.org/10.3329/bjp.v19i2.72787